Linezolid treatment of shunt-related cerebrospinal fluid infections in children: Clinical article

Journal of Neurosurgery: Pediatrics

Volumn 5, Issue 5, 2010, Pages 443-448

  Yilmaz, Adem ^a   Dalgic, Nazan ^a   Müslüman, Murat ^a   Sancar, Mesut ^b   Çolak, Ibrahim ^a   Aydin, Yunus ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Infection; Linezolid; Multidrug resistance; Ventriculoperitoneal shunt

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; GLUCOSE; LINEZOLID; MEROPENEM; PROTEIN; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BRAIN VENTRICLE PERITONEUM SHUNT; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONGENITAL HYDROCEPHALUS; CONGESTIVE HEART FAILURE; ENTEROCOCCUS FAECIUM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFANT; LEUKOCYTE COUNT; MALE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; PRESCHOOL CHILD; PRIORITY JOURNAL; SHUNT INFECTION;

ACETAMIDES; ANTI-INFECTIVE AGENTS; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTS; CHILD, PRESCHOOL; DEVICE REMOVAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; OXAZOLIDINONES; PNEUMOCOCCAL INFECTIONS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; VANCOMYCIN RESISTANCE; VENTRICULOPERITONEAL SHUNT;

EID: 77951770570     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2009.12.PEDS09421     Document Type: Article

References (50)

1. Bassetti M, Di Biagio A, Cenderello G, Del Bono V, Palermo A, Cruciani M, et al: Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA). J Infect 43:148-149, 2001 (Pubitemid 33077064)
2. Baysallar M, Izci Y, Kilic A, Avci IY, Senses Z, Doganci L: A case of ventricular drainage infection with a rare pathogen in cerebrospinal fluid: vancomycin-resistant Enterococcus faecium. Microb Drug Resist 12:59-62, 2006
3. Bayston R: Hydrocephalus shunt infections. J Antimicrob Chemother 34 (Suppl A):75-84, 1994
4. Bayston R, Ashraf W, Bhundia C: Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778-782, 2004 (Pubitemid 38660278)
5. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ: Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis 36:159-168, 2003 (Pubitemid 36143412)
6. Blount JP, Campbell JA, Haines SJ: Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am 4: 633-656, 1993
7. Boak LM, Li J, Spelman D, du Cros P, Nation RL, Rayner CR: Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis. Ann Pharmacother 40:1451-1455, 2006 (Pubitemid 44204979)
8. Bozdogan B, Esel D, Whitener C, Browne FA, Appelbaum PC: Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J Antimicrob Chemother 52:864-868, 2003 (Pubitemid 37407819)
9. Castro P, Soriano A, Escrich C, Villalba G, Sarasa M, Mensa J: Linezolid treatment of ventriculoperitoneal shunt infection without implant removal. Eur J Clin Microbiol Infect Dis 24:603-606, 2005 (Pubitemid 41456140)
10. Centers for Disease Control and Prevention (CDC): Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR Morb Mortal Wkly Rep 46: 765-766, 1997
11. Cha R, Brown WJ, Rybak MJ: Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 47:3960-3963, 2003 (Pubitemid 37485015)
12. Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML: Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 38:448-451, 2004 (Pubitemid 38200128)
13. Cockerill FR III, Hughes JG, Vetter EA, Mueller RA, Weaver AL, Ilstrup DM, et al: Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis 24:403-418, 1997
14. Cook AM, Ramsey CN, Martin CA, Pittman T: Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection. Pediatr Neurosurg 41:102-104, 2005 (Pubitemid 40976764)
15. da Silva PS, Monteiro Neto H, Sejas LM: Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child. Braz J Infect Dis 11:297-299, 2007 (Pubitemid 47099100)
16. Filka J, Huttova M, Tuharsky J, Sagat T, Kralinsky K, Krcmery V Jr: Nosocomial meningitis in children after ventriculoperitoneal shunt insertion. Acta Paediatr 88:576-578, 1999 (Pubitemid 29289230)
17. Gallagher RM, Pizer B, Ellison JA, Riordan FA: Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin. J Infect 57:410-413, 2008
18. Gander S: Bacterial biofilms: resistance to antimicrobial agents. J Antimicrob Chemother 37:1047-1050, 1996 (Pubitemid 26258051)
19. Gander S, Hayward K, Finch R: An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J Antimicrob Chemother 49:301-308, 2002 (Pubitemid 34162620)
20. George R, Leibrock L, Epstein M: Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804-811, 1979 (Pubitemid 10157871)
21. Gill CJ, Murphy MA, Hamer DH: Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid. J Infect 45:129-132, 2002
22. Graham PL, Ampofo K, Saiman L: Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J 21:798-800, 2002
23. Guevara JA, Zúccaro G, Trevisán A, Denoya CD: Bacterial adhesion to cerebrospinal fluid shunts. J Neurosurg 67:438-445, 1987 (Pubitemid 17128362)
24. Hachem R, Afif C, Gokaslan Z, Raad I: Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 20:432-434, 2001 (Pubitemid 32646371)
25. Haines SJ: Efficacy of antibiotic prophylaxis in clean neurosurgical operations. Neurosurgery 24:401-405, 1989
26. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135-136, 1997 (Pubitemid 27341646)
27. James HE, Walsh JW, Wilson HD, Connor JD: The management of cerebrospinal fluid shunt infections: a clinical experience. Acta Neurochir (Wien) 59:157-166, 1981 (Pubitemid 12143309)
28. Kanchanapoom T, Koirala J, Goodrich J, Agamah E, Khardori N: Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium. Diagn Microbiol Infect Dis 45:213-215, 2003 (Pubitemid 36349663)
29. Kaufman BA: Infections of cerebrospinal shunts, in Scheld WM, Whitley RS, Durack DT (eds): Infections of Central Nervous System, ed 2. Philadelphia: Lippincott-Raven, 1997, Vol 29, pp 555-577
30. Klibanov OM, Filicko JE, DeSimone JA Jr, Tice DS: Sensorineural hearing loss associated with intrathecal vancomycin. Ann Pharmacother 37:61-65, 2003 (Pubitemid 36068599)
31. Kosaka T, Kokufu T, Shime N, Sugioka N, Kato R, Hamaoka K, et al: Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients. Int J Antimicrob Agents 33:368-370, 2009
32. Krueger WA, Kottler B, Will BE, Heininger A, Guggenberger H, Unertl KE: Treatment of meningitis due to methicillinresistant Staphylococcus epidermidis with linezolid. J Clin Microbiol 42:929-932, 2004 (Pubitemid 38222703)
33. Langgartner M, Mutenthaler A, Haiden N, Pollak A, Berger A: Linezolid for treatment of catheter-related cerebrospinal fluid infections in preterm infants. Arch Dis Child Fetal Neonatal Ed 93:F397, 2008 (Letter)
34. Maranich AM, Rajnik M: Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid. Mil Med 173:927-929, 2008
35. Milstone AM, Dick J, Carson B, Siberry GK: Cerebrospinal fluid penetration and bacteriostatic activity of linezolid against Enterococcus faecalis in a child with a ventriculoperitoneal shunt infection. Pediatr Neurosurg 43:406-409, 2007 (Pubitemid 47367789)
36. Morissette I, Gourdeau M, Francoeur J: CSF shunt infections: a fifteen-year experience with emphasis on management and outcome. Can J Neurol Sci 20:118-122, 1993 (Pubitemid 23212862)
37. Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, et al: Safety and tolerability of linezolid in children. Pediatr Infect Dis J 22 (9 Suppl):S193-S200, 2003
38. Shaikh ZH, Peloquin CA, Ericsson CD: Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 33:375-379, 2001 (Pubitemid 32573988)
39. Singh-Naz N, Sleemi A, Pikis A, Patel KM, Campos JM: Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol 37:413-416, 1999 (Pubitemid 29056416)
40. Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C: Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature. Crit Care Med 29:2383-2385, 2001 (Pubitemid 34038174)
41. Swayne R, Rampling A, Newsom SW: Intraventricular vancomycin for treatment of shunt-associated ventriculitis. J Antimicrob Chemother 19:249-253, 1987 (Pubitemid 17019956)
42. Tan TQ: Update on the use of linezolid: a pediatric perspective. Pediatr Infect Dis J 23:955-956, 2004
43. Tenover FC, Biddle JW, Lancaster MV: Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 7:327-332, 2001
44. Turgut M, Alabaz D, Erbey F, Kocabas E, Erman T, Alhan E, et al: Cerebrospinal fluid shunt infections in children. Pediatr Neurosurg 41:131-136, 2005 (Pubitemid 40911587)
45. Viale P, Pagani L, Cristini F, Stefini R, Bergomi R, Colombini P, et al: Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 34:456-459, 2002 (Pubitemid 34823442)
46. Villani P, Regazzi MB, Marubbi F, Viale P, Pagani L, Cristini F, et al: Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 46:936-937, 2002 (Pubitemid 34157696)
47. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP: Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014-1021, 1984
48. Wilcox MH, Kite P, Mills K, Sugden S: In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm. J Antimicrob Chemother 47:171-175, 2001 (Pubitemid 32149522)
49. Yogev R: Cerebrospinal fluid shunt infections: a personal view. Pediatr Infect Dis 4:113-118, 1985 (Pubitemid 15133543)
50. Zeana C, Kubin CJ, Della-Latta P, Hammer SM: Vancomycinresistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis 33:477-482, 2001 (Pubitemid 32709579)